rs104894949
Variant summary
Our verdict is Likely pathogenic. The variant received 8 ACMG points: 8P and 0B. PVS1_StrongPM2PP5_Moderate
The NM_001011658.4(TRAPPC2):c.329C>G(p.Ser110*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_001011658.4 stop_gained
Scores
Clinical Significance
Conservation
Publications
- ciliopathyInheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
- Joubert syndrome 10Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- orofaciodigital syndrome IInheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae)
- retinitis pigmentosa 23Inheritance: XL Classification: STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- primary ciliary dyskinesiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- retinitis pigmentosaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- orofaciodigital syndrome type 6Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- Simpson-Golabi-Behmel syndrome type 2Inheritance: XL Classification: LIMITED Submitted by: G2P
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 8 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| TRAPPC2 | NM_001011658.4 | c.329C>G | p.Ser110* | stop_gained | Exon 6 of 6 | ENST00000380579.6 | NP_001011658.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| TRAPPC2 | ENST00000380579.6 | c.329C>G | p.Ser110* | stop_gained | Exon 6 of 6 | 1 | NM_001011658.4 | ENSP00000369953.1 | ||
| TRAPPC2 | ENST00000683983.1 | c.431C>G | p.Ser144* | stop_gained | Exon 6 of 6 | ENSP00000507474.1 | ||||
| TRAPPC2 | ENST00000359680.9 | c.329C>G | p.Ser110* | stop_gained | Exon 5 of 5 | 1 | ENSP00000352708.5 | |||
| TRAPPC2 | ENST00000458511.7 | c.329C>G | p.Ser110* | stop_gained | Exon 6 of 6 | 5 | ENSP00000392495.3 | |||
| TRAPPC2 | ENST00000518847.2 | c.329C>G | p.Ser110* | stop_gained | Exon 5 of 5 | 4 | ENSP00000428900.2 |
Frequencies
GnomAD3 genomes Cov.: 24
GnomAD4 exome Cov.: 18
GnomAD4 genome Cov.: 24
ClinVar
Submissions by phenotype
not provided Pathogenic:1
This sequence change creates a premature translational stop signal (p.Ser110*) in the TRAPPC2 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 31 amino acid(s) of the TRAPPC2 protein. This variant is not present in population databases (gnomAD no frequency). For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the TRAPPC2 protein in which other variant(s) (p.Arg122*) have been determined to be pathogenic (PMID: 11443194; Invitae). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. ClinVar contains an entry for this variant (Variation ID: 1457497). This premature translational stop signal has been observed in individuals with clinical features of spondyloepiphyseal dysplasia tarda (PMID: 12446987; Invitae).
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at